Avastin (bevacizumab) - Angiogenesis Inhibitor and Cancer Therapy

Print-Icon
Print

To meet the growing demand for licensed products and new drugs coming on stream, Genentech is increasing production capacity.
 
«Back

Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development